No Data
Insider Sale: Director at $SPRY (SPRY) Sells 50,000 Shares
ARS Pharmaceuticals Files for Approval of Experimental Allergic Reaction Treatment in Canada, UK
Institutional Investors May Overlook ARS Pharmaceuticals, Inc.'s (NASDAQ:SPRY) Recent US$56m Market Cap Drop as Long-term Gains Remain Positive
ARS Pharmaceuticals Says Express Scripts Has Added Neffy (Epinephrine Nasal Spray) To Its Commercial National Formularies
ARS Pharmaceuticals Announces Neffy (Epinephrine Nasal Spray) Is Available on Express Scripts Commercial National Formularies
ARS Pharmaceuticals to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
